Threshold Pharmaceuticals

Key FDA Decisions and Trial Results Coming in the Next 2 Months
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
Flag link:
8 Major FDA Decisions and Trial Results to Watch for in September
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
FDA
Achillion
odalasvir
AL-335
simeprevir
Amarin
Vascepa
Array Biopharma
binimetinib
Mast Therapeutics
vepoloxamer
Novavax
Threshold Pharmaceuticals
tarloxotinib
Flag link:
Threshold Pharmaceuticals posts 4Q profit
Threshold Pharmaceuticals posts 4Q profit
Yahoo/AP
Threshold Pharmaceuticals
earnings
Flag link:
Merck KGaA, Threshold drug fails in late-stage cancer trials
Merck KGaA, Threshold drug fails in late-stage cancer trials
Yahoo/Reuters
Merck KGaA
Threshold Pharmaceuticals
evofosfamide
Flag link:
Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer
Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer
Motley Fool
chemotherapy
cancer immunotherapies
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
targeted therapies
Pfizer
Xalkori
stem cells
OncoMed
tumor hypoxia
Threshold Pharmaceuticals
Flag link:
Threshold Pharmaceuticals posts 3Q loss
Threshold Pharmaceuticals posts 3Q loss
Yahoo/AP
Threshold Pharmaceuticals
earnings
Flag link:
2 Biotech Stocks That Could Skyrocket In The Next 12 Months
2 Biotech Stocks That Could Skyrocket In The Next 12 Months
Yahoo/Benzinga
biotech
Biocryst
Threshold Pharmaceuticals
Flag link:
3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double
3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double
Motley Fool
biotech
Xoma
Exelixis
Threshold Pharmaceuticals
Flag link:
Merck KGaA, Threshold win fast track for pancreatic cancer drug
Merck KGaA, Threshold win fast track for pancreatic cancer drug
Yahoo/Reuters
Merck KGaA
Threshold Pharmaceuticals
pancreatic cancer
FDA
fast track
evofosfamide
Flag link:
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Flag link:
Encouraging Initial Data From Ongoing Phase 1/2 Trial of TH-302 Plus Bortezomib (Velcade(R)) Plus Dexamethasone ("TBorD") in Patients With Relapsed/Refractory Multiple Myeloma Presented at ASH Annual Meeting
Encouraging Initial Data From Ongoing Phase 1/2 Trial of TH-302 Plus Bortezomib (Velcade(R)) Plus Dexamethasone ("TBorD") in Patients With Relapsed/Refractory Multiple Myeloma Presented at ASH Annual Meeting
Yahoo/MarketWired
TH-302
Threshold Pharmaceuticals
Multiple Myeloma
Flag link:
Threshold Pharmaceuticals posts 3Q loss, results miss Wall Street forecasts
Threshold Pharmaceuticals posts 3Q loss, results miss Wall Street forecasts
Yahoo/AP
earnings
Threshold Pharmaceuticals
Flag link:
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
phys.org
TH-302
Threshold Pharmaceuticals
glioblastoma
brain cancer
Flag link:
Biotech Stock Mailbag: Threshold, Galena, CytRx
Biotech Stock Mailbag: Threshold, Galena, CytRx
TheStreet.com
Threshold Pharmaceuticals
Galena Biopharma
CytRx
Flag link:
Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer
Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer
Seeking Alpha
Threshold Pharmaceuticals
non-small cell lung cancer
TH-302
Flag link:
Three Biotechs That Could Double
Three Biotechs That Could Double
Yahoo/Street Authority
Verastem
Versartis
Threshold Pharmaceuticals
Flag link:
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
Flag link:
3 Biotechs And The Feuerstein-Ratain Rule
3 Biotechs And The Feuerstein-Ratain Rule
Seeking Alpha
Ziopharm
Threshold Pharmaceuticals
Celsion
Flag link:
A Look at Three Biotech Movers
A Look at Three Biotech Movers
Motley Fool
Sarepta Therapeutics
Celsion
Threshold Pharmaceuticals
Flag link:
3 Biotech Stocks Surging Higher With Volume
3 Biotech Stocks Surging Higher With Volume
Seeking Alpha
Allergan
Keryx
MAP Pharmaceuticals
Threshold Pharmaceuticals
Flag link:

Pages